NIFTY 50 22795.9 ▼ (0.51%)
NIFTY NEXT 50 60466.8 ▼ (0.94%)
NIFTY 100 23274.05 ▼ (0.59%)
NIFTY MIDCAP 100 50486.2 ▼ (1.32%)
NIFTY SMALLCAP 100 15636.9 ▼ (0.7%)
NIFTY SMALLCAP 250 14683.4 ▼ (0.57%)
NIFTY MIDCAP SELECT 11198.9 ▼ (1.69%)
NIFTY TOTAL MARKET 11634.25 ▼ (0.67%)
NIFTY BANK 48981.2 ▼ (0.72%)
SENSEX 75311.06 ▼ (0.56%)
BSE BANKEX 55718.18 ▼ (0.82%)

Global Health ‘s Q3 2024-25 Latest News: Profit Rises by 15.64% YoY

[fetch_key]

Highlights

🔹 The presented financial data is Consolidated to provide a comprehensive overview of the company performance.
🔹 Sales over the Year and quarter: The company experienced a substantial growth of 13.31 % in the past year, decrease in net sales/revenue by -1.37 %.
🔹 Income over the Year and quarter: There has been decline in other income over the past year which is -26.93 %, Marginal decrease of -12.03% in other income during this quarter.
🔹 Profit over the Year and quarter: Significant improvement in profitability for Global Health Limited. Notable increase of 15.64 % in net profit Year to Year, Global Health Limited’s profitability increased by 9.2 % in this quarter.
🔹 EPS over the Year and quarter: EPS increased by 15.40 % Year to Year. EPS increased by 9.24 % in previous quarter. Positive impact on shareholders.

This analytical report on Global Health Limited stretches beyond conventional financial metrics to include an in-depth exploration of the company’s long-term strategic plans and their alignment with current market conditions. It examines the sustainability of the company’s business model in light of emerging market trends and competitive pressures. The insight provided by seasoned industry analysts adds depth to the evaluation, offering predictions that help in assessing the company’s position and potential movements in its stock price. For investors, this report serves as a crucial tool in understanding the intrinsic value of the company and strategizing their investment moves accordingly.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 832.602 Cr Rs. 956.555 Cr Rs. 943.436 Cr -1.37 % + 13.31 %
Expenses Rs. 620.51 Cr Rs. 728.26 Cr Rs. 705.67 Cr -3.1 % + 13.72 %
Operating Profit Rs. 212.09 Cr Rs. 228.3 Cr Rs. 237.77 Cr + 4.15 % + 12.11 %
OPM % 25.47 % 23.87 % 25.2 % + 1.33 % -0.27 %
Other Income Rs. 21.931 Cr Rs. 18.216 Cr Rs. 16.024 Cr -12.03 % -26.93 %
Interest Rs. 17.68 Cr Rs. 15.98 Cr Rs. 16.28 Cr + 1.88 % -7.92 %
Depreciation Rs. 43.98 Cr Rs. 49.43 Cr Rs. 48.45 Cr -1.98 % + 10.16 %
Profit before tax Rs. 172.36 Cr Rs. 181.11 Cr Rs. 189.06 Cr + 4.39 % + 9.69 %
Tax % 28.33 % 27.76 % 24.44 % -3.32 % -3.89 %
Net Profit Rs. 123.54 Cr Rs. 130.82 Cr Rs. 142.86 Cr + 9.2 % + 15.64 %
EPS in Rs Rs. 4.6 Rs. 4.87 Rs. 5.32 + 9.24 % + 15.65 %


Today, we’re looking at Global Health Limited’s financial performance for the Q3(Dec 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 13.31 %. However, it did see a marginal slip of -1.37 % from the previous quarter. Expenses decreased slightly by -3.1 % quarter-on-quarter, aligning with the annual rise of 13.72 %. Operating profit, while up 12.11 % compared to last year, faced a quarter-on-quarter increase of 4.15 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -0.27 %, but an expansion of 1.33 % sequentially. Other income fell by -12.03 % compared to the last quarter, despite an annual decline of -26.93 %. Interest expenses surged remarkably by 1.88 % from the previous quarter, yet the year-over-year decrease remains at a moderate -7.92 %. Depreciation costs fell by -1.98 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 10.16 %. Profit before tax grew annually by 9.69 % but saw an increase from the preceding quarter by 4.39 %.
Tax expenses as a percentage of profits decreased slightly by -3.89 % compared to last year, with a more notable quarter-on-quarter decrease of -3.32 %. Net profit rose by 15.64 % year-on-year but experienced a 9.2 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 15.65 % but a quarterly rise of 9.24 %. In summary, Global Health Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 832.602 Cr Rs. 956.555 Cr Rs. 943.436 Cr -1.37 % + 13.31 %
Expenses Rs. 620.51 Cr Rs. 728.26 Cr Rs. 705.67 Cr -3.1 % + 13.72 %
Operating Profit Rs. 212.09 Cr Rs. 228.3 Cr Rs. 237.77 Cr + 4.15 % + 12.11 %
Net Profit Rs. 123.54 Cr Rs. 130.82 Cr Rs. 142.86 Cr + 9.2 % + 15.64 %
EPS in Rs Rs. 4.6 Rs. 4.87 Rs. 5.32 + 9.24 % + 15.65 %


In reviewing Global Health Limited’s 2024-25(Q3) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 13.31 % year-on-year growth, although there was a slight dip of -1.37 % from the previous quarter. Expenses rose by 13.72 % compared to the previous year, with a decrease of -3.1 % quarter-on-quarter. Operating Profit surged by 12.11 % annually, and saw a 4.15 % increase from the last quarter.
Net Profit showed yearly increase of 15.64 %, and experienced a 9.2 % increase from the previous quarter. Earnings Per Share (EPS) rose by 15.65 % annually, however rose by 9.24 % compared to the last quarter. In essence, while Global Health Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.

Join our telegram for more updates

Stay Updated with Our YouTube Videos

Related Post